Study demonstrates that tissue-resident and circulating memory T cells cooperate in anti-tumor immunity – Science Daily
Science Daily |
Study demonstrates that tissue-resident and circulating memory T cells cooperate in anti-tumor immunity
Science Daily Immunotherapy, the use of the immune system to fight cancer, is revolutionizing treatment of this disease, and was selected by the journal Science as the major scientific advance of 2013. According to study leader David Sancho, “Cancer escapes the … |
|
MS News That Caught My Eye This Week: Stem Cell Cautions, Myelin Mystery, Amprya Study and Zinbryta in the EU
Multiple Sclerosis News Today I read a lot of comments on various social media sites from MS patients who have traveled outside the U.S. to be treated with stem cells. Some of these patients have reported excellent results and a reversal of symptoms. Others have died. There’s a new … |
|
Regulatory Recon: FDA Accepts Spark’s Gene Therapy Application; Amgen Gets CRL for Osteoporosis Candidate …
Regulatory Focus Regulatory Reconnaissance is our daily intelligence briefing for the regulatory affairs space, bringing you the top regulatory news stories from around the globe. Each weekday morning, we aim to bring you the latest highlights of new approvals … |
Philly.com |
Philly biotech’s first-ever gene therapy progresses with FDA
Philly.com If approved, the treatment would be the first gene therapy for a genetic disease in the United States. Spark’s treatment, called voretigene neparvovec, streams genes directly into the eye’s retina. It has been granted priority review by the FDA because … FDA embraces the first US application for a gene therapy, offering an accelerated test caseEndpoints News Spark files revolutionary gene therapy with FDApharmaphorum FDA accepts biologics license application for voretigene neparvovecHealio Nasdaq all 24 news articles » |
|
CNIC research holds potential to improve current cancer immunotherapy strategies
News-Medical.net Immunotherapy, the use of the immune system to fight cancer, is revolutionizing treatment of this disease, and was selected by the prestigious journal Science as the major scientific advance of 2013. According to study leader David Sancho, “Cancer … |
|
‘Organic gene therapy‘ could be effective treatment approach for serious blood disorders
News-Medical.net Genome therapy with beneficial natural mutation could lead to new treatment for life-threatening blood disorders. By introducing a beneficial natural mutation into blood cells using the gene-editing technique CRISPR, a UNSW Sydney-led team of … |